Please login to the form below

Atripla

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Atripla was produced by Gilead Sciences.

Gilead gets EU nod for TAF-based triple therapy for HIV

Atripla in 20016. ... Since then, Atripla has grown into a $3bn-plus product. "People living with HIV today are increasingly likely to be receiving treatment for other conditions - such as heart and liver disease -

ViiV and Janssen take long-acting HIV regimen into phase III

Gilead currently dominates the HIV treatment sector thanks to drugs like Truvada (emtricitabine and tenofovir disoproxil fumarate) and Atripla (favirenz/emtricitabine/tenofovir disoproxil fumarate), but ViiV is fighting back.

ViiV agrees $1.5bn deal to acquire BMS' HIV assets

cobicistat), Sustiva (efavirenz) and big-selling Atripla (efavirenz, emtricitabine, and tenofovir).

ViiV boosted by positive phase III results for HIV drug Triumeq

The current HIV fixed-dose combination market leader is by Gilead's Atripla (tenofovir, emtrcitabine and efavirenz), which in 2013 achieved sales of $3.6bn.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 (Next 4)

Data provided by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology

Featured jobs

Senior Account Manager / Account Director - Med Comms: Great salary and benefits

Scientific Director: Highly Competitive Salary &Benefits

Account Director – Global Healthcare PR: Salary TBC

Scientific Team Lead: Competitive Salary

Account Director: Negotiable

Account Manager, Healthcare Advertising: Salary TBC

Healthcare PR Director: £100, 000 – £120, 000 benefits

Editorial Director – Medical Education: Neg

Associate Medical Director: Salary TBC

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Director – Head of Public Affairs: Neg

Senior Account Manager - Med Comms: Highly Competitive Salary &Benefits

Account Manager- Manchester, Macclesfield or Glasgow: Negotiable

Medical Strategic Director, Healthcare Advertising Agency: Salary TBC

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Account Director - Digital: Great salary and benefits

Experienced Editor, London, Medical Communications: Competitive package

Senior Medical Writer (Remote Working): Competitive Salary Offered

Account Manager, Healthcare Communications: £32, 000 - £40, 000 benefits

Graduate Scientific Editor: DOE

Project / Account Manager (Medical Education): Salary TBC

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Lead Medical Copywriter, Healthcare Brand Communications, London: Excellent package

Senior Account Executive – Medical Communications: Salary TBC

In conversation with Pfizer’s Erik Nordkamp: Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...
Pharma social media: Posting frequency is down as companies take a ‘less is more’ approach...
The case for a second Brexit referendum: “We need the informed consent of the people”: Dr Phillip Lee MP is fighting to keep the UK in the EMA network - and for a second referendum...